[{"address1": "301 Binney Street", "address2": "3rd Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "857 259 3860", "website": "https://www.scholarrock.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGF\u00df) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 128, "companyOfficers": [{"maxAge": 1, "name": "Mr. Edward H. Myles MBA", "age": 52, "title": "Senior Advisor", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 720786, "exercisedValue": 0, "unexercisedValue": 857292}, {"maxAge": 1, "name": "Ms. Tracey M. Sacco M.B.A.", "age": 48, "title": "Chief Commercial Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 548855, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mo  Qatanani Ph.D.", "age": 51, "title": "Chief Scientific Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rushmie  Nofsinger", "title": "Vice President of Corporate Affairs & Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Junlin  Ho J.D.", "age": 45, "title": "General Counsel & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 563729, "exercisedValue": 0, "unexercisedValue": 112564}, {"maxAge": 1, "name": "Ms. Caryn  Parlavecchio", "age": 52, "title": "Chief Human Resources Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa Amaya Price", "title": "Senior Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  Iarrobino", "title": "Senior Vice President of Clinical Development & Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jing L. Marantz M.B.A., M.D., Ph.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth  Shafer Ph.D.", "title": "Chief Business Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 9, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 26.31, "open": 26.36, "dayLow": 25.72, "dayHigh": 28.1, "regularMarketPreviousClose": 26.31, "regularMarketOpen": 26.36, "regularMarketDayLow": 25.72, "regularMarketDayHigh": 28.1, "payoutRatio": 0.0, "beta": 0.576, "forwardPE": -13.023255, "volume": 1761817, "regularMarketVolume": 1761817, "averageVolume": 1088739, "averageVolume10days": 1738800, "averageDailyVolume10Day": 1738800, "bid": 27.88, "ask": 28.16, "bidSize": 1, "askSize": 7, "marketCap": 2656085504, "fiftyTwoWeekLow": 6.76, "fiftyTwoWeekHigh": 46.98, "fiftyDayAverage": 34.8463, "twoHundredDayAverage": 26.154575, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2174652928, "profitMargins": 0.0, "floatShares": 69786242, "sharesOutstanding": 94676800, "sharesShort": 16131337, "sharesShortPriorMonth": 15982742, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.17040001, "heldPercentInsiders": 0.01276, "heldPercentInstitutions": 1.16676, "shortRatio": 19.34, "shortPercentOfFloat": 0.3123, "impliedSharesOutstanding": 94860200, "bookValue": 3.929, "priceToBook": 7.1264954, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -246294000, "trailingEps": -2.47, "forwardEps": -2.15, "enterpriseToEbitda": -8.695, "52WeekChange": 1.1005251, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 28.0, "targetHighPrice": 57.0, "targetLowPrice": 45.0, "targetMeanPrice": 50.5, "targetMedianPrice": 50.0, "recommendationKey": "none", "numberOfAnalystOpinions": 8, "totalCash": 437278016, "totalCashPerShare": 4.619, "ebitda": -250116992, "totalDebt": 65126000, "quickRatio": 9.362, "currentRatio": 9.612, "debtToEquity": 17.667, "returnOnAssets": -0.40087003, "returnOnEquity": -0.82948, "grossProfits": -184550000, "freeCashflow": -111554872, "operatingCashflow": -200948992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SRRK", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "longName": "Scholar Rock Holding Corporation", "shortName": "Scholar Rock Holding Corporatio", "corporateActions": [], "postMarketTime": 1744413201, "regularMarketTime": 1744401600, "exchange": "NMS", "messageBoardId": "finmb_548810128", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 6.423415, "regularMarketPrice": 28.0, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1527255000000, "postMarketChangePercent": 1.0, "postMarketPrice": 28.28, "postMarketChange": 0.280001, "regularMarketChange": 1.6900005, "regularMarketDayRange": "25.72 - 28.1", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1088739, "fiftyTwoWeekLowChange": 21.24, "fiftyTwoWeekLowChangePercent": 3.1420116, "fiftyTwoWeekRange": "6.76 - 46.98", "fiftyTwoWeekHighChange": -18.98, "fiftyTwoWeekHighChangePercent": -0.40400168, "fiftyTwoWeekChangePercent": 110.05251, "earningsTimestamp": 1740657600, "earningsTimestampStart": 1746448200, "earningsTimestampEnd": 1746793800, "earningsCallTimestampStart": 1740662100, "earningsCallTimestampEnd": 1740662100, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.47, "epsForward": -2.15, "epsCurrentYear": -2.62386, "priceEpsCurrentYear": -10.671302, "fiftyDayAverageChange": -6.846298, "fiftyDayAverageChangePercent": -0.19647132, "twoHundredDayAverageChange": 1.8454247, "twoHundredDayAverageChangePercent": 0.070558384, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Scholar Rock Holding", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]